Thermo Fisher Scientific Inc. (NYSE:TMO) is One of billionaire Steve Cohen’s large-cap stock picks with the highest upside potential.. On April 28, Thermo Fisher Scientific Inc. (NYSE:TMO) opened a new bioprocess design center.

Copyright: kadmy / 123RF stock image

The new center in Plainville, Massachusetts is designed to bring life-changing treatments to patients. In addition, customers will be able to partner with company experts to tackle complex bioprocessing challenges. The center features 4,000 square feet of laboratory and training space where customers can access comprehensive bioproduction solutions and expert scientists and engineers.

The opening of the Bioprocess Design Center is an important milestone as Thermo Fisher Scientific looks to expand drug development. This is in part because the center will help customers unlock productivity gains, reduce scale risks and shorten timelines. The center is also positioned to strengthen connections and collaboration across the country by creating more opportunities for innovation.

Thermo Fisher Scientific Inc. (NYSE:TMO) is a global leader serving science, providing advanced analytical instruments, laboratory equipment, software, services, consumables and chemicals. It enables pharmaceutical/biotech, healthcare, academia, and government customers to accelerate life sciences research, solve complex analytical challenges, and improve patient diagnostics.

While we recognize TMO’s potential as an investment, we believe some AI stocks offer more upside potential and less downside risk. If you’re looking for an extremely undervalued AI stock that stands to benefit significantly from the Trump-era tariff and on-shoring trend, check out our free report Best Short Term AI Stocks.

Read next: 10 Best AI Stocks for 2026 According to Billionaire David Tepper And 9 Best Green Energy Penny Stocks to Invest in.

Disclosure: None. Follow Insider Monkey on Google News..